Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 a » 19 _ (Expand Search), 19 p (Expand Search), 1 a (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 a » 19 _ (Expand Search), 19 p (Expand Search), 1 a (Expand Search)
-
8641
-
8642
Conjunctural hunger and structural obesity in the global scenario: reflections on what Covid-19 masks reveal
Published 2022“…<div><p>ABSTRACT This essay is a reflection on the interconnection of the Covid-19 pandemic, social inequality, food insecurity and obesity in the global scenario. …”
-
8643
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05....
Published 2025“…Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. …”
-
8644
COVID-19 vaccine receipt and intent among US adults by month (January-May, 2021).
Published 2021“…<p>Vaccine hesitancy decreased among adults each month from January to May, mostly due to a decrease in the response, “probably not” (-7.1 percentage points (%) [95% CI -7.2, -6.9]) versus “definitely not” (-1.8% [95% CI -1.9, -1.7]).…”
-
8645
Data_Sheet_1_Two-year follow-up of the COVID-19 pandemic in Mexico.PDF
Published 2023“…Background<p>After the initial outbreak in China (December 2019), the World Health Organization declared COVID-19 a pandemic on March 11<sup>th</sup>, 2020. This paper aims to describe the first 2 years of the pandemic in Mexico.…”
-
8646
Laparoscopic or robotic intraoperative management to minimize aerosol dispersion: Adaptations to the context of the COVID-19 pandemic
Published 2021“…Extreme intra and extra-hospital measures have been implemented to decrease the transmission and dissemination of the COVID-19. …”
-
8647
DataSheet1_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.PDF
Published 2022“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”
-
8648
-
8649
Autapses play a crucial role in PV interneuron’s sustained firing at high frequencies.
Published 2025“…Summary data of the maximum firing frequency per group revealing a decrease in the maximum firing frequency in PV interneurons that do not have autapses (<i>t test of control with vs. without autapse; n = 19 cells from 9 mice per group, *p < 0.01; t test of cuprizone with vs. without autapse; n = 17 cells from 8 mice per group, p = 0.0722</i>). …”
-
8650
-
8651
-
8652
-
8653
Image_6_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8654
Image_4_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8655
Image_3_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8656
Image_1_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8657
Image_5_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8658
Image_2_AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized con...
Published 2022“…</p>Conclusion<p>The AYURAKSHA kit is associated with reduced COVID-19 positivity and with a better quality of life among the trial group. …”
-
8659
datasheet1_COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments.docx
Published 2021“…<p>The effect of immunosuppressant treatments on the incidence of coronavirus disease (COVID-19) remains largely unknown. We studied the association between the pre-exposure to disease-modifying antirheumatic drugs (DMARDs) that decrease immunological responses and the incidence of COVID-19 to explore the possible effects of these treatments in early manifestations of the disease. …”
-
8660
Palliative care to cancer patients: how COVID-19 pandemic could affect quality of care
Published 2022“…<div><p>ABSTRACT Objective To evaluate the impact of COVID-19 pandemic on the care delivered to hospitalized cancer patients in end-of-life. …”